Key facts
- It has raised $100K; the latest was Angel (individual) ($100K) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Claisen
- ·The full record, as it builds
Funding rounds
No funding rounds for Claisen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Claisen
Developer of an online healthtech and telemedicine platform designed to offer personalized treatment for gastrointestinal issues. The company's platform uses a proprietary symptom-matching algorithm and tailored care pathways, enabling individuals with digestive conditions to access customized treatment and improve their overall well-being.
- Sector
- Healthcare
- HQ
- Brighton, MA, United States
- Founded
- 2025
- Employees
- 8
- Website
- claisen.com/
- Ownership
- Privately Held (backing)
Claisen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Claisen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Claisen in its N-PORT filings yet. We sweep new filings monthly.